GILD 240809 69.00C (GILD240809C69000) Stock Options, News & Quotes

US OptionsDetailed Quotes

GILD240809C69000

Watchlist

6.62
0.000.00%

15min DelayTrading Aug 8 14:13 ET

0.00High0.00Low

Intraday

5D
Daily

News

Express News | Gilead Sciences Inc. : Morgan Stanley Raises Target Price to $79.00 From $74.00
Reuters41minutes ago
Gilead Sciences (GILD) Gets a Hold From Cantor Fitzgerald
TipRanks08:49 ET · Ratings
Gilead Sciences: Hold Rating Affirmed Amid Mixed Performance and Cautious Outlook
TipRanks08:14 ET · Ratings
Gilead Sciences Is Maintained at Outperform by BMO Capital
Dow Jones08:03 ET
Gilead Sciences Analyst Ratings
Benzinga07:53 ET · Ratings
Express News | Gilead : BMO Raises Target Price to $85 From $80
Reuters07:27 ET

Comments

Moomoo Recap US

17 hours ago

Columns S&P 500 Tries Its Best to Rebound With Best Day In A Year | Wall Street Today

After the S&P 500 had its worst day since 2022 Monday, it rebounded with its best one day point climb since January of 2023 Thursday.
Just past the 4 pm ET close, the $S&P 500 Index (.SPX.US)$ climbed 2.30%, the $Dow Jones Industrial Average (.DJI.US)$ climbed 1.76%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 2.87%.
MACRO
Thursday in macroeconomics, initial jobless claims came in at 233k, lower than 250k l...

Herd on Wall Street: mooving news stories and updates!

TrendTrader

17 hours ago

Looking for 80

$Gilead Sciences (GILD.US)$

Meltyy

Aug 6 02:59

📅 FDA PDUFA Update…

🚨 This Week’s PDUFA:
$Humacyte (HUMA.US)$ : 🤔
⇨ Human Acellular Vessel (HAV)™
‣ Vascular Trauma
‣ PDUFA: 8/10/24 (BLA)
🗓️ Last Week’s AdCom & PDUFAs:
$Zevra Therapeutics (ZVRA.US)$ : Favorable AdCom 👍
🗳️ 11-5 votes in favor
⇨ Arimoclomol
‣ Niemann-Pick disease type C
‣ AdCom: 8/2/24 (NDA)
$Adaptimmune Therapeutics (ADAP.US)$ : Approved 🎉
⇨ TECELRA (afamitresgene autoleucel)
‣ Synovial sarcoma
‣ PDUFA: 8/4/24 (BLA)
$GlaxoSmithKline (GSK.US)$ : Approved 🎉
⇨ Jemperli
‣ Endometria...

Qianmeng

Aug 1 17:05

So no more HIV no more covid?

$Vir Biotechnology (VIR.US)$ Good news is my position in GILD is safe. Sick but hell if you boost price to 20, I’ll love to leave. Oncology is crowded path, bad idea.
your own platform is most valuable and made 2 Billion for the company. You just let people go…

Goodjobguys

Aug 1 09:43

7 Cheap But Risky Biotech Stocks? Funds moving from big corporations to Small Caps?

$Immuneering (IMRX.US)$ $SPDR S&P Biotech ETF (XBI.US)$ $iShares Biotechnology ETF (IBB.US)$ $S&P 500 Index (.SPX.US)$ $BioAtla (BCAB.US)$ $Gilead Sciences (GILD.US)$ $Affimed NV (AFMD.US)$ $Instil Bio (TIL.US)$ $Nkarta (NKTX.US)$
Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF XBI 0.05% drop nearly 50%.
The other most-watched exchange-traded fund that tracks the biotech secto...